EZCORP Smashes Q2 Estimates as Shorts Steadily Retreat
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
EZCORP enters the post-earnings session with one of the cleanest beats it has delivered in years — and the short community has been quietly signalling as much for weeks.
Q2 results hit the tape on May 6. Adjusted EPS came in at $0.58, against a consensus estimate of $0.41 — a 41% beat. Revenue of $434.9M topped estimates by $38M, with the headline figure hitting $446.9M against a $390.7M forecast. That follows a similarly strong February print, when the stock jumped 16.7% on results day before extending gains another 10.8% over the following five sessions. The record-setting quarter in Q1, which included an 11% jump in sales and a 28% EBITDA rise in the Latin America segment, had already set expectations high — and EZCORP cleared the bar again.
Short sellers have been reading this tea correctly. From a peak of 22% of the free float in early April, short interest has trimmed steadily to 18.4% — a decline of roughly 3.6 percentage points in six weeks, with the sharpest drop occurring around April 9-10. That's still a meaningful short position, and FINRA's most recent official data pegged days-to-cover at 12.6, which means exiting at current volumes is no quick exercise. Borrow costs are low — around 0.48% annualised — so there's no acute squeeze pressure from the lending side. Availability is running at a moderate level, with approximately half the lending pool currently committed. Nothing in the borrow market suggests a forced unwind; this has been an orderly, deliberate reduction in short exposure.
Options positioning adds a distinctive wrinkle. The put/call ratio is running near its 20-day average at 0.15, essentially unchanged over the past two weeks and nowhere near the 52-week high of 2.12 set earlier in the year. Options traders were neither hedging aggressively into earnings nor pressing for upside — the market was close to neutral. That neutrality now looks like it underpriced the beat. The RSI had already climbed to 79.7 heading into results, reflecting a stock up 23% over the past month and 68% year-to-date.
Analyst coverage has gradually shifted constructive. Canaccord Genuity raised its price target to $40 from $34 in early April — the most recent action and the only one within the past 30 days — keeping a Buy rating. Before that, the same firm had lifted targets following both the November and February earnings prints, consistently marking up estimates after each beat. Stephens, holding an Equal-Weight, raised its target to $26 in February. The mean target heading into tonight's print was $34, now below the current price of $33.41 before the post-close reaction. If Canaccord's $40 target sets the directional tone for Street revisions, the target consensus needs a significant refresh. The P/E multiple has re-rated 3.4 turns higher over the past 30 days to 17.4x — pricing in momentum but not obviously stretched for a company beating by these margins. EV/EBITDA at 9.4x is similarly undemanding. The 90-day EPS momentum factor ranks in the 92nd percentile of the universe — one of the highest beats-against-estimates scores across ORTEX's coverage set.
Institutional ownership reflects a broadly supportive base. BlackRock and FMR each hold around 11% of shares outstanding, with Fidelity adding over 2 million shares in its most recently reported period. Capital Research built a position of over a million shares through year-end 2025. The profile is large-cap passive plus some active conviction — not a speculative register prone to sudden exits. Insider activity through early March was entirely sell-side: directors and C-suite officers were trimming into the price strength, with the Chief Legal Officer, two independent directors, and the Chief Internal Audit Officer all selling between mid-February and early March at prices in the $24-$27 range. Those trades look well-timed in hindsight, though the stock has since run well clear of those levels.
The next watch point is straightforward: how the Street responds to tonight's beat, how quickly analyst targets are revised above $40, and whether the 18% short interest begins a faster unwind or holds as scepticism around the sustainability of Latin America margins and gold-price sensitivity lingers.
Stocks in this article
See the live data behind this article on ORTEX.
Open EZPW on ORTEX →How this article was generated
- Generated
- 6 May 2026, 21:20
- Data as of
- 6 May 2026, 21:19
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsInstitutional positioningORTEX Alpha signals
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.